In this work, we present the advantage of TE-averaged PRESS approach to reliably quantify brain glutamate and glycine levels in vivo in patients with psychosis. Since glutamtergic dysregulation and NMDA receptor hypofunction are implicated in the pathophysiology of major psychiatric conditions, non-invasive in vivo assessments of glutamate and its NMDA receptor modulator, glycine, would be of great importance. We found significantly elevated glutamate and glycine levels in the anterior cingulate cortex and parieto-occipital cortex of patients with first-episode psychosis as compared to healthy controls, suggesting increased brain glutamatergic activity with compensatory attempts to correct for NMDA receptor hypofunction.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords